Market research
VA21.F Vapotherm, Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 18M
- P/E ratio
- Not available
- Analyst target
- 41.5
- Dividend yield
- 0.0%
- Beta
- -1.23
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US9221071072
- Market cap
- 18M
- P/E ratio
- Not available
- Analyst target
- 41.5
- Dividend yield
- 0.0%
- Beta
- -1.23
About
About Vapotherm, Inc
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the VA21.F discussion.
5 years, 5 months ago
Vapotherm, Inc is currently in a long term downtrend where the price is trading 14.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
Vapotherm, Inc's total revenue rose by 214.4% to $41M since the same quarter in the previous year.
Its net income has dropped by 38.0% to $-17M since the same quarter in the previous year.
Finally, its free cash flow grew by 12.0% to $-11M since the same quarter in the previous year.
Based on the above factors, Vapotherm, Inc gets an overall score of 3/5.